🇺🇸 FDA

Intelligence · Clinical Pipeline

Hospital Authority Pipeline

All ClinicalTrials.gov programs at Hospital Authority — phase, modality, and trial IDs.

Programs
322

Quick answer

Hospital Authority has 322 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Levofloxacin

    Hospital Authority, Hong Kong

    Urinary Tract Infection

    approved small molecule active

    1 trial

  2. Lucentis

    Hospital Authority, Hong Kong

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  3. Methotrexate plus sulfasalazine

    Hospital Authority, Hong Kong

    Rheumatoid Arthritis

    approved small molecule terminated

    1 trial

  4. Metronidazole

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  5. MgSO4 plus Ropivacaine

    Hospital Authority, Hong Kong

    Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block

    approved small molecule completed

    1 trial

  6. Minoxidil lotion 1%

    Hospital Authority, Hong Kong

    Eyebrow Hypotrichosis

    approved small molecule completed

    1 trial

  7. Minoxidil lotion 2%

    Hospital Authority, Hong Kong

    Hypotrichosis of Eyebrows

    approved small molecule completed

    1 trial

  8. Moxonidine 0.2 MG

    Hospital Authority, Hong Kong

    Central Sympathetic Nervous System Diseases

    approved small molecule completed

    1 trial

  9. Oral prednisolone (30mg/day) for 28 days

    Hospital Authority, Hong Kong

    Esophageal Neoplasms

    approved small molecule active

    1 trial

  10. Oxycodone

    Hospital Authority, Hong Kong

    Postcraniotomy Pain

    approved small molecule completed

    1 trial

  11. Paliperidone ER

    Hospital Authority, Hong Kong

    Schizophrenia

    approved small molecule completed

    1 trial

  12. Remifentanil

    Hospital Authority, Hong Kong

    Labor Pain

    approved small molecule active

    1 trial

  13. Renin-angiotensin system blockers

    Hospital Authority, Hong Kong

    Diabetes

    approved small molecule active

    1 trial

  14. Rifaximin Oral Tablet

    Hospital Authority, Hong Kong

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule completed

    1 trial

  15. Rosuvastatin

    Hospital Authority, Hong Kong

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial

  16. SGLT2 inhibitor (Empagliflozin 25 MG)

    Hospital Authority, Hong Kong

    Type2 Diabetes

    approved small molecule active

    1 trial

  17. SYSTANE™ Hydration Lubricant Eye Drops

    Hospital Authority, Hong Kong

    Dry Eye Syndromes

    approved small molecule active

    1 trial

  18. Simethicone

    Hospital Authority, Hong Kong

    Colonoscopy

    approved small molecule completed

    1 trial

  19. Simvastatin

    Hospital Authority, Hong Kong

    Obesity

    approved small molecule active

    1 trial

  20. Topical Anesthetic

    Hospital Authority, Hong Kong

    Radial Artery Spasm

    approved small molecule active

    1 trial

  21. Transepicardial with Transseptal CD 133+ Implantation

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved mab completed

    1 trial

  22. Trimebutine 100 MG

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  23. Valproic acid

    Hospital Authority, Hong Kong

    Drug Resistant Epilepsy

    approved small molecule active

    1 trial

  24. Vemlidy

    Hospital Authority, Hong Kong

    Chronic Hepatitis b

    approved small molecule active

    1 trial

  25. Vitamin D3

    Hospital Authority, Hong Kong

    Bronchiectasis

    approved small molecule active

    1 trial

  26. Z-Brace interbody fusion device

    Hospital Authority, Hong Kong

    Cervical Disc Degeneration

    approved other active

    1 trial

  27. conbercept

    Hospital Authority, Hong Kong

    Polypoidal Choroidal Vasculopathy

    approved small molecule completed

    1 trial

  28. conventional dose epinephrine

    Hospital Authority, Hong Kong

    Croup

    approved small molecule active

    1 trial

  29. fluticasone/salmeterol, tiotropium

    Hospital Authority, Hong Kong

    COPD

    approved small molecule active

    1 trial

  30. gastric scintigraphy

    Hospital Authority, Hong Kong

    Functional Dyspepsia

    approved other terminated

    1 trial

  31. isoniazid, rifampin, pyrazinamide

    Hospital Authority, Hong Kong

    Hepatitis

    approved small molecule active

    1 trial

  32. mirabegron

    Hospital Authority, Hong Kong

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  33. moxifloxacin

    Hospital Authority, Hong Kong

    Intra-abdominal Infection

    approved small molecule completed

    1 trial

  34. omeprazole plus amoxicillin

    Hospital Authority, Hong Kong

    Duodenal Ulcer

    approved small molecule completed

    1 trial

  35. pegylated interferon alpha and plus ribavirin

    Hospital Authority, Hong Kong

    Chronic Hepatitis C

    approved small molecule completed

    1 trial

  36. video capsule endoscopy

    Hospital Authority, Hong Kong

    Overt Obscure Gastrointestinal Bleeding

    approved other completed

    1 trial

  37. 0 ul of ondansetron

    Hospital Authority, Hong Kong

    Blood Coagulation Disorder

    small molecule active

    1 trial

  38. 0.9% NaCl physiological saline

    Hospital Authority, Hong Kong

    Acute Respiratory Tract Infections

    small molecule active

    1 trial

  39. 18F-PMPBB3 (APN-1607) PET imaging

    Hospital Authority, Hong Kong

    Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan

    other completed

    1 trial

  40. 25% Carbohydrate solution (CHO drinking)

    Hospital Authority, Hong Kong

    Type2diabetes

    other completed

    1 trial

  41. 5-gene classification model

    Hospital Authority, Hong Kong

    ABO Blood Type Incompatible Kidney Transplantation

    other completed

    1 trial

  42. AREG-TRIGGER

    Hospital Authority, Hong Kong

    PCOS

    small molecule completed

    1 trial

  43. Abbreviated non-contrast MRI of the liver

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma

    other active

    1 trial

  44. Acetaminophen

    Hospital Authority, Hong Kong

    Elbow Fracture

    small molecule completed

    1 trial

  45. Andrositol Plus

    Hospital Authority, Hong Kong

    Male Infertility

    other active

    1 trial

  46. Anti-PD1

    Hospital Authority, Hong Kong

    Nasopharyngeal Carcinoma (NPC)

    small molecule completed

    1 trial

  47. Artificial intelligence

    Hospital Authority, Hong Kong

    Internal Disease

    other active

    1 trial

  48. Bupivacain

    Hospital Authority, Hong Kong

    Arthroplasty, Replacement, Knee

    small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does Hospital Authority have?

322 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.